<DOC>
	<DOC>NCT01902602</DOC>
	<brief_summary>The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments . In addition, data are collected on the immune system as well as for food and sleep quality.</brief_summary>
	<brief_title>Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia</brief_title>
	<detailed_description />
	<mesh_term>Muscle Hypertonia</mesh_term>
	<criteria>Resistant Hypertension &gt; 140 / &gt; 90mmHg Inclusion age : 45 + Regular monitoring of blood levels considered premedication to lower blood pressure for at least 3 weeks before the preliminary investigation consistent Men and Women derailed diabetes renal impairment , renal creatinine clear &lt;50 ml Non austherapierte cancer / tumor patients Non adjusted thyroid dysfunction BMI&gt; 35 LVEF &lt;limit ( " 35% " ) Peripheral AVK ( ABI measurement ) &gt; Stage II regurgitation &gt; Stage I abdominal aneurysm infections acute febrile infections with temperature &gt; 38.5 Â° C COPD and asthma to stage III dyspnea NYHA &gt; Stage III z.n. Stroke shorter than 12 weeks Acute liver failure Acute Apoplexy Severe poisoning drug addiction hyperthyroidism Hypotension hypocalcemia hypoglycemia ozone allergy pregnancy clotting problems ( hemophilia ) preexisting condition with hemoglobin &lt; 9mg/dl Fresh myocardial infarction Internal bleeding thrombocytopenia Acute alcohol Citrus allergy when using sodium citrate</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>